Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

United Therapeutics Corporation Share Price

UTHR

NSQ

$476.13

+$0.28

(0.06%)

Industry: Biotechnology Sector: Health Care

United Therapeutics Corporation Analyst Forecast

Overview Returns Financials Ratios News FAQs

United Therapeutics Corporation Share Price Chart

United Therapeutics Corporation Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$20.49B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

17.9175

Volume

This is the total number of shares traded during the most recent trading day.

214.80K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.86

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$266.98 L

$519.99 H

$476.13

About United Therapeutics Corporation, Common Stock

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company involved in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. United Therapeutics Corporation was incorporated in 1996 and is headquartered in Silver Spring, Maryland. more

Industry: BiotechnologySector: Health Care

United Therapeutics Corporation Stock Returns

Time Frame	UTHR	Sector	S&P500
1-Week Return	-0.58%	0.91%	2.13%
1-Month Return	-1.3%	-0.72%	-0.47%
3-Month Return	3.16%	2.24%	1.29%
6-Month Return	57.98%	19.1%	7.71%
1-Year Return	28.43%	7.15%	14.7%
3-Year Return	85.99%	16.96%	67.75%
5-Year Return	184.02%	33.23%	76.25%
10-Year Return	276.21%	142.74%	271.83%

Time Frame	UTHR	Sector	S&P500
1-Week Return	-26.16%	60.38%	200.11%
1-Month Return	-14.72%	-8.42%	-5.57%
3-Month Return	13.45%	9.40%	5.34%
6-Month Return	152.77%	42.54%	16.25%
1-Year Return	28.43%	7.15%	14.70%
3-Year Return	22.98%	5.36%	18.82%
5-Year Return	23.22%	5.91%	12.00%
10-Year Return	14.17%	9.27%	14.03%

United Therapeutics Corporation Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	1.48B	1.69B	1.94B	2.33B	2.88B	[{"date":"2020-12-31","value":51.55,"profit":true},{"date":"2021-12-31","value":58.58,"profit":true},{"date":"2022-12-31","value":67.29,"profit":true},{"date":"2023-12-31","value":80.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	108.10M	122.50M	146.70M	257.50M	309.70M	[{"date":"2020-12-31","value":34.9,"profit":true},{"date":"2021-12-31","value":39.55,"profit":true},{"date":"2022-12-31","value":47.37,"profit":true},{"date":"2023-12-31","value":83.14,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	1.38B	1.56B	1.79B	2.07B	2.57B	[{"date":"2020-12-31","value":53.56,"profit":true},{"date":"2021-12-31","value":60.87,"profit":true},{"date":"2022-12-31","value":69.7,"profit":true},{"date":"2023-12-31","value":80.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	92.71%	92.73%	92.42%	88.94%	89.24%	[{"date":"2020-12-31","value":99.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.67,"profit":true},{"date":"2023-12-31","value":95.91,"profit":true},{"date":"2024-12-31","value":96.23,"profit":true}]

Operating Expenses	781.60M	1.01B	809.90M	885.10M	1.19B	[{"date":"2020-12-31","value":65.64,"profit":true},{"date":"2021-12-31","value":84.58,"profit":true},{"date":"2022-12-31","value":68.02,"profit":true},{"date":"2023-12-31","value":74.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	593.60M	555.90M	979.70M	1.18B	1.38B	[{"date":"2020-12-31","value":43.11,"profit":true},{"date":"2021-12-31","value":40.37,"profit":true},{"date":"2022-12-31","value":71.15,"profit":true},{"date":"2023-12-31","value":86.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	50.40M	36.10M	(16.30M)	192.80M	318.20M	[{"date":"2020-12-31","value":15.84,"profit":true},{"date":"2021-12-31","value":11.35,"profit":true},{"date":"2022-12-31","value":-5.12,"profit":false},{"date":"2023-12-31","value":60.59,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	638.90M	593.90M	950.60M	1.27B	1.54B	[{"date":"2020-12-31","value":41.51,"profit":true},{"date":"2021-12-31","value":38.59,"profit":true},{"date":"2022-12-31","value":61.77,"profit":true},{"date":"2023-12-31","value":82.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	124.10M	118.10M	223.30M	289.50M	343.90M	[{"date":"2020-12-31","value":36.09,"profit":true},{"date":"2021-12-31","value":34.34,"profit":true},{"date":"2022-12-31","value":64.93,"profit":true},{"date":"2023-12-31","value":84.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	514.80M	475.80M	727.30M	984.80M	1.20B	[{"date":"2020-12-31","value":43.08,"profit":true},{"date":"2021-12-31","value":39.81,"profit":true},{"date":"2022-12-31","value":60.86,"profit":true},{"date":"2023-12-31","value":82.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Income From Continuous Operations	514.80M	475.80M	727.30M	984.80M	1.20B	[{"date":"2020-12-31","value":43.08,"profit":true},{"date":"2021-12-31","value":39.81,"profit":true},{"date":"2022-12-31","value":60.86,"profit":true},{"date":"2023-12-31","value":82.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	514.80M	475.80M	727.30M	984.80M	1.20B	[{"date":"2020-12-31","value":43.08,"profit":true},{"date":"2021-12-31","value":39.81,"profit":true},{"date":"2022-12-31","value":60.86,"profit":true},{"date":"2023-12-31","value":82.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	11.58	10.03	15.02	19.84	24.60	[{"date":"2020-12-31","value":47.07,"profit":true},{"date":"2021-12-31","value":40.77,"profit":true},{"date":"2022-12-31","value":61.06,"profit":true},{"date":"2023-12-31","value":80.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	13.63%	14.88%	20.20%	23.63%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":57.7,"profit":true},{"date":"2022-12-31","value":62.98,"profit":true},{"date":"2023-12-31","value":85.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	-	13.32%	19.76%	75.53%	20.27%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":17.64,"profit":true},{"date":"2022-12-31","value":26.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":26.84,"profit":true}]
Gross Profit	-	13.66%	14.50%	15.67%	24.04%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":56.8,"profit":true},{"date":"2022-12-31","value":60.3,"profit":true},{"date":"2023-12-31","value":65.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	-	0.02%	(0.33%)	(3.77%)	0.34%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":6.37,"profit":true},{"date":"2022-12-31","value":-98.54,"profit":false},{"date":"2023-12-31","value":-1117.82,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	-	28.85%	(19.58%)	9.29%	34.53%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":83.56,"profit":true},{"date":"2022-12-31","value":-56.71,"profit":false},{"date":"2023-12-31","value":26.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	(6.35%)	76.24%	20.95%	16.21%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-8.33,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.47,"profit":true},{"date":"2024-12-31","value":21.27,"profit":true}]
Total Non-Operating Income/Expense	-	(28.37%)	(145.15%)	(1282.82%)	65.04%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-43.62,"profit":false},{"date":"2022-12-31","value":-223.17,"profit":false},{"date":"2023-12-31","value":-1972.31,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	-	(7.04%)	60.06%	34.05%	20.77%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-11.73,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":56.7,"profit":true},{"date":"2024-12-31","value":34.59,"profit":true}]
Income Taxes	-	(4.83%)	89.08%	29.65%	18.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-5.43,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":33.28,"profit":true},{"date":"2024-12-31","value":21.1,"profit":true}]
Income After Taxes	-	(7.58%)	52.86%	35.40%	21.35%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.33,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.98,"profit":true},{"date":"2024-12-31","value":40.4,"profit":true}]

Income From Continuous Operations	-	(7.58%)	52.86%	35.40%	21.35%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.33,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.98,"profit":true},{"date":"2024-12-31","value":40.4,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(7.58%)	52.86%	35.40%	21.35%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.33,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.98,"profit":true},{"date":"2024-12-31","value":40.4,"profit":true}]

EPS (Diluted)	-	(13.39%)	49.75%	32.09%	23.99%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-26.9,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.5,"profit":true},{"date":"2024-12-31","value":48.22,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	748.90M	735.90M	794.40M	798.60M	799.50M	[{"date":"2024-09-30","value":93.67,"profit":true},{"date":"2024-12-31","value":92.05,"profit":true},{"date":"2025-03-31","value":99.36,"profit":true},{"date":"2025-06-30","value":99.89,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Cost of Revenue	83.10M	75.90M	92.50M	87.60M	100.90M	[{"date":"2024-09-30","value":82.36,"profit":true},{"date":"2024-12-31","value":75.22,"profit":true},{"date":"2025-03-31","value":91.67,"profit":true},{"date":"2025-06-30","value":86.82,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Profit	665.80M	660.00M	701.90M	711.00M	698.60M	[{"date":"2024-09-30","value":93.64,"profit":true},{"date":"2024-12-31","value":92.83,"profit":true},{"date":"2025-03-31","value":98.72,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":98.26,"profit":true}]
Gross Margin	88.90%	89.69%	88.36%	89.03%	87.38%	[{"date":"2024-09-30","value":99.13,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":98.52,"profit":true},{"date":"2025-06-30","value":99.27,"profit":true},{"date":"2025-09-30","value":97.43,"profit":true}]

Operating Expenses	322.70M	302.30M	319.10M	346.50M	310.10M	[{"date":"2024-09-30","value":93.13,"profit":true},{"date":"2024-12-31","value":87.24,"profit":true},{"date":"2025-03-31","value":92.09,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":89.49,"profit":true}]
Operating Income	343.10M	357.70M	382.80M	364.50M	388.50M	[{"date":"2024-09-30","value":88.31,"profit":true},{"date":"2024-12-31","value":92.07,"profit":true},{"date":"2025-03-31","value":98.53,"profit":true},{"date":"2025-06-30","value":93.82,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Non-Operating Income/Expense	85.20M	80.20M	85.70M	87.90M	92.90M	[{"date":"2024-09-30","value":91.71,"profit":true},{"date":"2024-12-31","value":86.33,"profit":true},{"date":"2025-03-31","value":92.25,"profit":true},{"date":"2025-06-30","value":94.62,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Pre-Tax Income	388.60M	396.50M	423.50M	408.40M	438.00M	[{"date":"2024-09-30","value":88.72,"profit":true},{"date":"2024-12-31","value":90.53,"profit":true},{"date":"2025-03-31","value":96.69,"profit":true},{"date":"2025-06-30","value":93.24,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Income Taxes	79.50M	95.20M	101.30M	98.90M	99.30M	[{"date":"2024-09-30","value":78.48,"profit":true},{"date":"2024-12-31","value":93.98,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":97.63,"profit":true},{"date":"2025-09-30","value":98.03,"profit":true}]
Income After Taxes	309.10M	301.30M	322.20M	309.50M	338.70M	[{"date":"2024-09-30","value":91.26,"profit":true},{"date":"2024-12-31","value":88.96,"profit":true},{"date":"2025-03-31","value":95.13,"profit":true},{"date":"2025-06-30","value":91.38,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Income From Continuous Operations	309.10M	301.30M	322.20M	309.50M	338.70M	[{"date":"2024-09-30","value":91.26,"profit":true},{"date":"2024-12-31","value":88.96,"profit":true},{"date":"2025-03-31","value":95.13,"profit":true},{"date":"2025-06-30","value":91.38,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	309.10M	301.30M	322.20M	309.50M	338.70M	[{"date":"2024-09-30","value":91.26,"profit":true},{"date":"2024-12-31","value":88.96,"profit":true},{"date":"2025-03-31","value":95.13,"profit":true},{"date":"2025-06-30","value":91.38,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

EPS (Diluted)	6.39	6.19	6.63	6.41	7.16	[{"date":"2024-09-30","value":89.25,"profit":true},{"date":"2024-12-31","value":86.45,"profit":true},{"date":"2025-03-31","value":92.59,"profit":true},{"date":"2025-06-30","value":89.53,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	(1.74%)	7.95%	0.53%	0.11%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-21.84,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":6.65,"profit":true},{"date":"2025-09-30","value":1.42,"profit":true}]
Cost of Revenue	-	(8.66%)	21.87%	(5.30%)	15.18%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-39.62,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-24.22,"profit":false},{"date":"2025-09-30","value":69.42,"profit":true}]
Gross Profit	-	(0.87%)	6.35%	1.30%	(1.74%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-13.72,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":20.42,"profit":true},{"date":"2025-09-30","value":-27.47,"profit":false}]
Gross Margin	-	0.88%	(1.48%)	0.76%	(1.85%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-168.53,"profit":false},{"date":"2025-06-30","value":86.79,"profit":true},{"date":"2025-09-30","value":-210.75,"profit":false}]

Operating Expenses	-	(6.32%)	5.56%	8.59%	(10.51%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-73.62,"profit":false},{"date":"2025-03-31","value":64.72,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-122.34,"profit":false}]
Operating Income	-	4.26%	7.02%	(4.78%)	6.58%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":60.64,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-68.13,"profit":false},{"date":"2025-09-30","value":93.83,"profit":true}]
Total Non-Operating Income/Expense	-	(5.87%)	6.86%	2.57%	5.69%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-85.57,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":37.43,"profit":true},{"date":"2025-09-30","value":82.95,"profit":true}]
Pre-Tax Income	-	2.03%	6.81%	(3.57%)	7.25%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":28.05,"profit":true},{"date":"2025-03-31","value":93.95,"profit":true},{"date":"2025-06-30","value":-49.19,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income Taxes	-	19.75%	6.41%	(2.37%)	0.40%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":32.45,"profit":true},{"date":"2025-06-30","value":-12,"profit":false},{"date":"2025-09-30","value":2.05,"profit":true}]
Income After Taxes	-	(2.52%)	6.94%	(3.94%)	9.43%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-26.75,"profit":false},{"date":"2025-03-31","value":73.52,"profit":true},{"date":"2025-06-30","value":-41.78,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Income From Continuous Operations	-	(2.52%)	6.94%	(3.94%)	9.43%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-26.75,"profit":false},{"date":"2025-03-31","value":73.52,"profit":true},{"date":"2025-06-30","value":-41.78,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(2.52%)	6.94%	(3.94%)	9.43%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-26.75,"profit":false},{"date":"2025-03-31","value":73.52,"profit":true},{"date":"2025-06-30","value":-41.78,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

EPS (Diluted)	-	(3.13%)	7.10%	(3.31%)	11.70%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-26.75,"profit":false},{"date":"2025-03-31","value":60.7,"profit":true},{"date":"2025-06-30","value":-28.31,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	2.17B	2.32B	3.38B	3.55B	3.87B	[{"date":"2020-12-31","value":55.94,"profit":true},{"date":"2021-12-31","value":59.98,"profit":true},{"date":"2022-12-31","value":87.26,"profit":true},{"date":"2023-12-31","value":91.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	2.45B	2.85B	2.66B	3.62B	3.49B	[{"date":"2020-12-31","value":67.69,"profit":true},{"date":"2021-12-31","value":78.69,"profit":true},{"date":"2022-12-31","value":73.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.52,"profit":true}]
Total Assets	4.62B	5.17B	6.04B	7.17B	7.36B	[{"date":"2020-12-31","value":62.67,"profit":true},{"date":"2021-12-31","value":70.19,"profit":true},{"date":"2022-12-31","value":82.08,"profit":true},{"date":"2023-12-31","value":97.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	323.30M	305.40M	343.20M	804.40M	738.10M	[{"date":"2020-12-31","value":40.19,"profit":true},{"date":"2021-12-31","value":37.97,"profit":true},{"date":"2022-12-31","value":42.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":91.76,"profit":true}]
Non-current Liabilities	896.50M	904.80M	904.60M	377.80M	181.90M	[{"date":"2020-12-31","value":99.08,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.98,"profit":true},{"date":"2023-12-31","value":41.76,"profit":true},{"date":"2024-12-31","value":20.1,"profit":true}]
Total Liabilities	1.22B	1.21B	1.25B	1.18B	920.00M	[{"date":"2020-12-31","value":97.76,"profit":true},{"date":"2021-12-31","value":96.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.74,"profit":true},{"date":"2024-12-31","value":73.73,"profit":true}]

Total Shareholders' equity
Common Stock	700.00K	700.00K	700.00K	700.00K	800.00K	[{"date":"2020-12-31","value":87.5,"profit":true},{"date":"2021-12-31","value":87.5,"profit":true},{"date":"2022-12-31","value":87.5,"profit":true},{"date":"2023-12-31","value":87.5,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	3.84B	4.32B	5.04B	6.03B	7.22B	[{"date":"2020-12-31","value":53.16,"profit":true},{"date":"2021-12-31","value":59.75,"profit":true},{"date":"2022-12-31","value":69.82,"profit":true},{"date":"2023-12-31","value":83.45,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	(430.50M)	(333.80M)	(190.80M)	(30.20M)	(775.60M)	[{"date":"2020-12-31","value":-43050000000,"profit":false},{"date":"2021-12-31","value":-33380000000,"profit":false},{"date":"2022-12-31","value":-19080000000,"profit":false},{"date":"2023-12-31","value":-3020000000,"profit":false},{"date":"2024-12-31","value":-77560000000,"profit":false}]
Total Shareholders' equity	3.40B	3.96B	4.80B	5.98B	6.44B	[{"date":"2020-12-31","value":52.69,"profit":true},{"date":"2021-12-31","value":61.44,"profit":true},{"date":"2022-12-31","value":74.44,"profit":true},{"date":"2023-12-31","value":92.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	4.62B	5.17B	6.04B	7.17B	7.36B	[{"date":"2020-12-31","value":62.67,"profit":true},{"date":"2021-12-31","value":70.19,"profit":true},{"date":"2022-12-31","value":82.08,"profit":true},{"date":"2023-12-31","value":97.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	7.22%	45.48%	5.05%	9.09%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":15.87,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":11.1,"profit":true},{"date":"2024-12-31","value":20,"profit":true}]
Non-current Assets	-	16.25%	(6.37%)	35.73%	(3.48%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":45.48,"profit":true},{"date":"2022-12-31","value":-17.83,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-9.75,"profit":false}]
Total Assets	-	12.01%	16.94%	18.57%	2.75%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":64.65,"profit":true},{"date":"2022-12-31","value":91.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":14.8,"profit":true}]

Total Liabilities
Current Liabilities	-	(5.54%)	12.38%	134.38%	(8.24%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4.12,"profit":false},{"date":"2022-12-31","value":9.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-6.13,"profit":false}]
Non-current Liabilities	-	0.93%	(0.02%)	(58.24%)	(51.85%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.39,"profit":false},{"date":"2023-12-31","value":-6290.16,"profit":false},{"date":"2024-12-31","value":-5600.73,"profit":false}]
Total Liabilities	-	(0.79%)	3.11%	(5.26%)	(22.18%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-25.33,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-169.21,"profit":false},{"date":"2024-12-31","value":-713.86,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	-	14.29%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	12.39%	16.86%	19.53%	19.83%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":62.5,"profit":true},{"date":"2022-12-31","value":85,"profit":true},{"date":"2023-12-31","value":98.5,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	(22.46%)	(42.84%)	(84.17%)	2468.21%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.91,"profit":false},{"date":"2022-12-31","value":-1.74,"profit":false},{"date":"2023-12-31","value":-3.41,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	16.60%	21.16%	24.77%	7.67%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":67.03,"profit":true},{"date":"2022-12-31","value":85.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":30.98,"profit":true}]

Total Liabilities & Shareholders Equity	-	12.01%	16.94%	18.57%	2.75%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":64.65,"profit":true},{"date":"2022-12-31","value":91.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":14.8,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	4.00B	3.87B	3.94B	3.83B	3.49B	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":96.84,"profit":true},{"date":"2025-03-31","value":98.49,"profit":true},{"date":"2025-06-30","value":95.66,"profit":true},{"date":"2025-09-30","value":87.34,"profit":true}]
Non-current Assets	3.12B	3.49B	3.80B	4.08B	3.86B	[{"date":"2024-09-30","value":76.52,"profit":true},{"date":"2024-12-31","value":85.52,"profit":true},{"date":"2025-03-31","value":93.21,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":94.51,"profit":true}]
Total Assets	7.12B	7.36B	7.74B	7.91B	7.35B	[{"date":"2024-09-30","value":90.07,"profit":true},{"date":"2024-12-31","value":93.12,"profit":true},{"date":"2025-03-31","value":97.92,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":92.96,"profit":true}]

Total Liabilities
Current Liabilities	873.40M	738.10M	721.50M	527.10M	546.30M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":84.51,"profit":true},{"date":"2025-03-31","value":82.61,"profit":true},{"date":"2025-06-30","value":60.35,"profit":true},{"date":"2025-09-30","value":62.55,"profit":true}]
Non-current Liabilities	148.80M	181.90M	215.20M	207.30M	214.60M	[{"date":"2024-09-30","value":69.14,"profit":true},{"date":"2024-12-31","value":84.53,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":96.33,"profit":true},{"date":"2025-09-30","value":99.72,"profit":true}]
Total Liabilities	1.02B	920.00M	936.70M	734.40M	760.90M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":90,"profit":true},{"date":"2025-03-31","value":91.64,"profit":true},{"date":"2025-06-30","value":71.85,"profit":true},{"date":"2025-09-30","value":74.44,"profit":true}]

Total Shareholders' equity
Common Stock	700.00K	800.00K	800.00K	800.00K	800.00K	[{"date":"2024-09-30","value":87.5,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	6.92B	7.22B	7.54B	7.85B	8.19B	[{"date":"2024-09-30","value":84.48,"profit":true},{"date":"2024-12-31","value":88.16,"profit":true},{"date":"2025-03-31","value":92.09,"profit":true},{"date":"2025-06-30","value":95.87,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Other Stockholders' Equity	(828.10M)	(775.60M)	(736.80M)	(681.10M)	(1.60B)	[{"date":"2024-09-30","value":-82810000000,"profit":false},{"date":"2024-12-31","value":-77560000000,"profit":false},{"date":"2025-03-31","value":-73680000000,"profit":false},{"date":"2025-06-30","value":-68110000000,"profit":false},{"date":"2025-09-30","value":-160330000000,"profit":false}]
Total Shareholders' equity	6.10B	6.44B	6.81B	7.17B	6.59B	[{"date":"2024-09-30","value":85.05,"profit":true},{"date":"2024-12-31","value":89.83,"profit":true},{"date":"2025-03-31","value":94.89,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":91.87,"profit":true}]

Total Liabilities & Shareholders Equity	7.12B	7.36B	7.74B	7.91B	7.35B	[{"date":"2024-09-30","value":90.07,"profit":true},{"date":"2024-12-31","value":93.12,"profit":true},{"date":"2025-03-31","value":97.92,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":92.96,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(3.16%)	1.70%	(2.87%)	(8.70%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-185.89,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-168.45,"profit":false},{"date":"2025-09-30","value":-511.36,"profit":false}]
Non-current Assets	-	11.77%	9.00%	7.28%	(5.49%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":76.47,"profit":true},{"date":"2025-06-30","value":61.89,"profit":true},{"date":"2025-09-30","value":-46.65,"profit":false}]
Total Assets	-	3.38%	5.16%	2.12%	(7.04%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":65.56,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":41.08,"profit":true},{"date":"2025-09-30","value":-136.51,"profit":false}]

Total Liabilities
Current Liabilities	-	(15.49%)	(2.25%)	(26.94%)	3.64%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-425.28,"profit":false},{"date":"2025-03-31","value":-61.74,"profit":false},{"date":"2025-06-30","value":-739.69,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	-	22.24%	18.31%	(3.67%)	3.52%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":82.3,"profit":true},{"date":"2025-06-30","value":-16.5,"profit":false},{"date":"2025-09-30","value":15.83,"profit":true}]
Total Liabilities	-	(10.00%)	1.82%	(21.60%)	3.61%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-277.08,"profit":false},{"date":"2025-03-31","value":50.31,"profit":true},{"date":"2025-06-30","value":-598.52,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	14.29%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	4.35%	4.46%	4.10%	4.31%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":97.58,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":91.96,"profit":true},{"date":"2025-09-30","value":96.67,"profit":true}]
Other Stockholders' Equity	-	(6.34%)	(5.00%)	(7.56%)	135.40%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-4.68,"profit":false},{"date":"2025-03-31","value":-3.69,"profit":false},{"date":"2025-06-30","value":-5.58,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	5.62%	5.64%	5.38%	(8.13%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":99.78,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":95.5,"profit":true},{"date":"2025-09-30","value":-144.29,"profit":false}]

Total Liabilities & Shareholders Equity	-	3.38%	5.16%	2.12%	(7.04%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":65.56,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":41.08,"profit":true},{"date":"2025-09-30","value":-136.51,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	755.70M	598.20M	802.50M	978.00M	1.33B	[{"date":"2020-12-31","value":56.94,"profit":true},{"date":"2021-12-31","value":45.08,"profit":true},{"date":"2022-12-31","value":60.47,"profit":true},{"date":"2023-12-31","value":73.69,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	(738.50M)	(486.90M)	(811.50M)	(719.60M)	417.20M	[{"date":"2020-12-31","value":-177.01,"profit":false},{"date":"2021-12-31","value":-116.71,"profit":false},{"date":"2022-12-31","value":-194.51,"profit":false},{"date":"2023-12-31","value":-172.48,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	(16.90M)	44.80M	75.40M	(11.90M)	(1.25B)	[{"date":"2020-12-31","value":-22.41,"profit":false},{"date":"2021-12-31","value":59.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-15.78,"profit":false},{"date":"2024-12-31","value":-1664.19,"profit":false}]

Net Change in Cash	300.00K	156.10M	66.40M	246.50M	489.50M	[{"date":"2020-12-31","value":0.06,"profit":true},{"date":"2021-12-31","value":31.89,"profit":true},{"date":"2022-12-31","value":13.56,"profit":true},{"date":"2023-12-31","value":50.36,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	696.40M	477.40M	663.70M	747.60M	1.08B	[{"date":"2020-12-31","value":64.45,"profit":true},{"date":"2021-12-31","value":44.18,"profit":true},{"date":"2022-12-31","value":61.42,"profit":true},{"date":"2023-12-31","value":69.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(20.84%)	34.15%	21.87%	35.70%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-58.39,"profit":false},{"date":"2022-12-31","value":95.68,"profit":true},{"date":"2023-12-31","value":61.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(34.07%)	66.67%	(11.32%)	(157.98%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-51.1,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-16.99,"profit":false},{"date":"2024-12-31","value":-236.96,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(365.09%)	68.30%	(115.78%)	10444.54%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-3.5,"profit":false},{"date":"2022-12-31","value":0.65,"profit":true},{"date":"2023-12-31","value":-1.11,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	51933.33%	(57.46%)	271.23%	98.58%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.11,"profit":false},{"date":"2023-12-31","value":0.52,"profit":true},{"date":"2024-12-31","value":0.19,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(31.45%)	39.02%	12.64%	44.54%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-70.6,"profit":false},{"date":"2022-12-31","value":87.61,"profit":true},{"date":"2023-12-31","value":28.38,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	377.20M	341.20M	461.20M	191.70M	562.10M	[{"date":"2024-09-30","value":67.11,"profit":true},{"date":"2024-12-31","value":60.7,"profit":true},{"date":"2025-03-31","value":82.05,"profit":true},{"date":"2025-06-30","value":34.1,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	(114.90M)	(123.20M)	(164.70M)	(299.90M)	140.90M	[{"date":"2024-09-30","value":-81.55,"profit":false},{"date":"2024-12-31","value":-87.44,"profit":false},{"date":"2025-03-31","value":-116.89,"profit":false},{"date":"2025-06-30","value":-212.85,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	(64.10M)	(74.70M)	(93.80M)	(198.60M)	(956.00M)	[{"date":"2024-09-30","value":-6410000000,"profit":false},{"date":"2024-12-31","value":-7470000000,"profit":false},{"date":"2025-03-31","value":-9380000000,"profit":false},{"date":"2025-06-30","value":-19860000000,"profit":false},{"date":"2025-09-30","value":-95600000000,"profit":false}]

Net Change in Cash	198.20M	143.30M	202.70M	(306.80M)	(253.00M)	[{"date":"2024-09-30","value":97.78,"profit":true},{"date":"2024-12-31","value":70.7,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-151.36,"profit":false},{"date":"2025-09-30","value":-124.81,"profit":false}]

Free Cash Flow
Free Cash Flow	300.70M	254.50M	386.30M	129.50M	351.60M	[{"date":"2024-09-30","value":77.84,"profit":true},{"date":"2024-12-31","value":65.88,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":33.52,"profit":true},{"date":"2025-09-30","value":91.02,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(9.54%)	35.17%	(58.43%)	193.22%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-4.94,"profit":false},{"date":"2025-03-31","value":18.2,"profit":true},{"date":"2025-06-30","value":-30.24,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	7.22%	33.69%	82.09%	(146.98%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":8.8,"profit":true},{"date":"2025-03-31","value":41.03,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-179.05,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	16.54%	25.57%	111.73%	381.37%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":4.34,"profit":true},{"date":"2025-03-31","value":6.7,"profit":true},{"date":"2025-06-30","value":29.3,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(27.70%)	41.45%	(251.36%)	(17.54%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-66.82,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-606.39,"profit":false},{"date":"2025-09-30","value":-42.3,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(15.36%)	51.79%	(66.48%)	171.51%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-8.96,"profit":false},{"date":"2025-03-31","value":30.2,"profit":true},{"date":"2025-06-30","value":-38.76,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

United Therapeutics Corporation Ratios

United Therapeutics Corporation Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	UTHR
Cash Ratio	5.07
Current Ratio	6.40
Quick Ratio	6.07

United Therapeutics Corporation Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	UTHR
ROA (LTM)	13.14%
ROE (LTM)	20.04%

United Therapeutics Corporation Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	UTHR
Debt Ratio Lower is generally better. Negative is bad.	0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.90

United Therapeutics Corporation Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	UTHR
Trailing PE	17.92
Forward PE	15.20
P/S (TTM)	6.84
P/B	3.09
Price/FCF	61
EV/R	5.51
EV/Ebitda	9.73
PEG	1.43

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is United Therapeutics Corporation share price today?

United Therapeutics Corporation (UTHR) share price today is $476.13

Can Indians buy United Therapeutics Corporation shares?

Yes, Indians can buy shares of United Therapeutics Corporation (UTHR) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in UTHR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of United Therapeutics Corporation be purchased?

Yes, you can purchase fractional shares of United Therapeutics Corporation (UTHR) via the Vested app. You can start investing in United Therapeutics Corporation (UTHR) with a minimum investment of $1.

How to invest in United Therapeutics Corporation shares from India?

You can invest in shares of United Therapeutics Corporation (UTHR) via Vested in three simple steps:

Click on Sign Up or Invest in UTHR stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in United Therapeutics Corporation shares

What is United Therapeutics Corporation 52-week high and low stock price?

The 52-week high price of United Therapeutics Corporation (UTHR) is $519.99. The 52-week low price of United Therapeutics Corporation (UTHR) is $266.98.

What is United Therapeutics Corporation price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of United Therapeutics Corporation (UTHR) is 17.9175

What is United Therapeutics Corporation price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of United Therapeutics Corporation (UTHR) is 3.09

What is United Therapeutics Corporation dividend yield?

The dividend yield of United Therapeutics Corporation (UTHR) is 0.00%

What is the Market Cap of United Therapeutics Corporation?

The market capitalization of United Therapeutics Corporation (UTHR) is $20.49B

What is United Therapeutics Corporation's stock symbol?

The stock symbol (or ticker) of United Therapeutics Corporation is UTHR

How Can Investors Use United Therapeutics Corporation Share Price Data for Long-Term Investment Decisions?

Consider the share price of United Therapeutics Corporation as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether United Therapeutics Corporation has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from United Therapeutics Corporation shares for Indian investors?

When investing in United Therapeutics Corporation shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the United Therapeutics Corporation stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare United Therapeutics Corporation share price with other stocks in the same sector?

Rather than merely checking the share price of United Therapeutics Corporation and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that United Therapeutics Corporation stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

United Therapeutics Corporation Share Price

United Therapeutics Corporation Analyst Forecast

United Therapeutics Corporation Share Price Chart

United Therapeutics Corporation Key Stock Metrics

About United Therapeutics Corporation, Common Stock

United Therapeutics Corporation Stock Returns

United Therapeutics Corporation Financials

United Therapeutics Corporation Ratios

United Therapeutics Corporation Liquidity Ratios

United Therapeutics Corporation Asset Efficiency Ratios

United Therapeutics Corporation Liability Ratios

United Therapeutics Corporation Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

United Therapeutics Corporation Share Price

United Therapeutics Corporation Analyst Forecast

United Therapeutics Corporation Share Price Chart

United Therapeutics Corporation Key Stock Metrics

About United Therapeutics Corporation, Common Stock

United Therapeutics Corporation Stock Returns

United Therapeutics Corporation Financials

United Therapeutics Corporation Ratios

United Therapeutics Corporation Liquidity Ratios

United Therapeutics Corporation Asset Efficiency Ratios

United Therapeutics Corporation Liability Ratios

United Therapeutics Corporation Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²